series-c-plus
Stage
2015
Founded
2
Investors
About
BridgeBio is a biopharmaceutical company that discovers, finances and develops targeted medicines for patients with genetic diseases and cancers. It advances drug candidates from discovery through clinical development and regulatory processes.
Explore BridgeBio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.